It will be important to study the potential of BDNF as a biomarker in pediatric ABI, specifically as adult findings cannot be generalized to children given differences in etiologies, mechanisms, and biological responses to brain injury, ongoing and rapid brain development, and the unique psychosocial environments of children. This evidence concerns the gene BDNF and injury.